GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates

分组1 - GSK reported quarterly earnings of $0.68 per share, exceeding the Zacks Consensus Estimate of $0.64 per share, and up from $0.59 per share a year ago, representing an earnings surprise of +6.25% [1] - The company achieved revenues of $11.46 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.41%, and an increase from $10.4 billion year-over-year [2] - GSK has outperformed the S&P 500 with an 8.8% increase in share price since the beginning of the year, compared to the S&P 500's gain of 1.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $1.20 on revenues of $10.05 billion, and for the current fiscal year, it is $4.87 on revenues of $44.39 billion [7] - The Medical - Biomedical and Genetics industry, to which GSK belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]